118 related articles for article (PubMed ID: 82488)
1. Proteins of herpes virus type 2 IV. Leukocyte inhibition responses to type common antigen(s) in cervix cancer and recurrent herpetic infections.
Bell RB; Aurelian L; Cohen GH
Cell Immunol; 1978 Nov; 41(1):86-102. PubMed ID: 82488
[No Abstract] [Full Text] [Related]
2. [Immunohistochemical study of condyloma and and carcinoembryonic antigens in the uterine cervix in human papilloma virus infection and neoplasia].
Alcántara-Vázquez A; Rodríguez-Martínez HA; Gómez-Ramírez AM; Cruz-Ortiz H; Orozco-Estéves H
Rev Invest Clin; 1985; 37(4):291-6. PubMed ID: 3006200
[No Abstract] [Full Text] [Related]
3. [Human papillomavirus infection and carcinogenesis of cancer of uterine cervix. II. Immunoperoxidase localization of papilloma-virus antigen in tissues of the uterine cervix].
Shu LL; Yang XZ
Zhonghua Zhong Liu Za Zhi; 1987 Nov; 9(6):430-2, 23. PubMed ID: 2838240
[TBL] [Abstract][Full Text] [Related]
4. Sero-epidemiology of herpes type-2 virus and carcinoma of the cervix in Ibadan.
Adelusi B; Osunkoya BO; Fabiyi A
Afr J Med Med Sci; 1977 Jun; 6(2):95-102. PubMed ID: 416672
[TBL] [Abstract][Full Text] [Related]
5. Herpes type-2 virus antigens in human cervical carcinoma.
Adelusi B; Osunkoya BO; Fabiyi A
Obstet Gynecol; 1976 May; 47(5):545-8. PubMed ID: 772507
[TBL] [Abstract][Full Text] [Related]
6. A, B & H isoantigens in cervical lesions.
Bisht D; Misra V; Gupta SC; Mehrotra R; Garg S
Indian J Pathol Microbiol; 1998 Jan; 41(1):11-4. PubMed ID: 9581070
[TBL] [Abstract][Full Text] [Related]
7. Neutralization, immunofluorescence and complement fixation tests in identification of antibody to a herpesvirus type 2-induced, tumor-specific antigen in sera from squamous cervical carcinoma.
Aurelian L; Strandberg JD; Marcus RL
Prog Exp Tumor Res; 1974; 19():165-81. PubMed ID: 4612606
[No Abstract] [Full Text] [Related]
8. Herpes simplex virus II antigen in adenocarcinoma of the uterine cervix.
Bhatia A; Ashokraj G
Indian J Pathol Microbiol; 1988 Apr; 31(2):40-4. PubMed ID: 2844663
[No Abstract] [Full Text] [Related]
9. Demonstration of tumor associated antigen in squamous cell carcinoma of cervix by immunodiffusion.
Tsai WS; Chiang WT; Wei PY; Alexander ER
Taiwan Yi Xue Hui Za Zhi; 1976 Sep; 75(9):489-96. PubMed ID: 827599
[No Abstract] [Full Text] [Related]
10. The antigenicity and immunology of human cervical squamous cell carcinoma: a review.
McCoy JP; Haines HG
Am J Obstet Gynecol; 1981 Jun; 140(3):329-36. PubMed ID: 7018244
[TBL] [Abstract][Full Text] [Related]
11. Antigenic deletion in cervical neoplasia.
Ashley C; Kirkland JA; Stanley MA
Pathology; 1974 Oct; 6(4):329-35. PubMed ID: 4615290
[No Abstract] [Full Text] [Related]
12. Possible role of Herpesvirus hominis, type 2, in human cervical cancer.
Aurelian L
Fed Proc; 1972; 31(6):1651-9. PubMed ID: 4351374
[No Abstract] [Full Text] [Related]
13. Circulatory and cellular immune responses to squamous cell carcinoma of the uterine cervix.
Chiang WT; Wei PY; Alexander ER
Am J Obstet Gynecol; 1976 Sep; 126(1):116-21. PubMed ID: 786019
[TBL] [Abstract][Full Text] [Related]
14. [Detection of herpes simplex virus antigen in human cervical carcinoma tissue].
Xu ZH
Zhonghua Fu Chan Ke Za Zhi; 1986 Jul; 21(4):238-41, 254. PubMed ID: 3021401
[No Abstract] [Full Text] [Related]
15. Herpesvirus hominis: from latency to carcinogenesis?
Aurelian L
Johns Hopkins Med J Suppl; 1973; 2():245-66. PubMed ID: 4137697
[No Abstract] [Full Text] [Related]
16. Leukocyte migration inhibition assay of tumor immunity in patients with cervical squamous cell carcinoma.
Rivera ES; Hersh EM; Bowen JM; Barnett JW; Wharton T; Murphy SG
Cancer; 1979 Jun; 43(6):2297-305. PubMed ID: 455220
[No Abstract] [Full Text] [Related]
17. Cellular immunity as a host response to squamous carcinoma of the cervix.
Goldstein MS; Shore B; Gusberg SB
Am J Obstet Gynecol; 1971 Nov; 111(6):751-5. PubMed ID: 5166388
[No Abstract] [Full Text] [Related]
18. Seroepidemiologic studies of herpesvirus type 2 and carcinoma of the cervix. 3. Houston, Texas.
Adam E; Kaufman RH; Melnick JL; Levy AH; Rawls WE
Am J Epidemiol; 1972 Dec; 96(6):427-42. PubMed ID: 4345340
[No Abstract] [Full Text] [Related]
19. [Nonspecific immunoreactivity in women with dysplasia and cancer of the uterine cervix].
Tosner J; Havel V; Turková M; Fixa B; Zaydlar K
Cesk Gynekol; 1984 Jun; 49(5):338-43. PubMed ID: 6467397
[No Abstract] [Full Text] [Related]
20. Herpesvirus type 2 and cervical carcinoma.
Melnick JL; Rawls WE
Ann N Y Acad Sci; 1970 Oct; 174(2):993-8. PubMed ID: 4322798
[No Abstract] [Full Text] [Related]
[Next] [New Search]
